The Los Angeles Post
U.S. World Business Lifestyle
Today: April 02, 2025
Today: April 02, 2025
Pratik Jain

Pratik Jain

Staff Writer

Latest From Pratik Jain

Business|Finance|Health

Abbott says market overestimating sales hit from new diabetes drugs

Abbott Laboratories said the market was overestimating the hit to sales of its glucose monitoring products from growing popularity of new diabetes drugs,

Abbott says market overestimating sales hit from new diabetes drugs
News|US

US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery

The U.S.

US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery
News|US

US Justice Department takes step to make marijuana use a less serious crime

The U.S.

US Justice Department takes step to make marijuana use a less serious crime
Health|News|Science|US

US FDA staff raises concerns over data from MDMA-based PTSD therapy

The U.S. health regulator's staff said on Friday data on the psychedelic drug MDMA for post-traumatic stress disorder was difficult to interpret, and raised

US FDA staff raises concerns over data from MDMA-based PTSD therapy
US

US FDA panel votes against first MDMA-based PTSD treatment

Advisers to the U.S.

US FDA panel votes against first MDMA-based PTSD treatment
Business|Health|Science

Nestle's health arm to buy first-ever fecal transplant pill

Nestle Health Science will buy the rights to Seres Therapeutics' Vowst, the companies said on Thursday, gaining full access to the first-ever pill alternative to fecal

Business|Finance|Stock Markets|US

Geron surges after winning first US FDA approval for blood disorder drug

Shares of Geron surged more than 20% on Friday, a day after the company gained its first approval from the U.S.

Geron surges after winning first US FDA approval for blood disorder drug
Business|Health|Science

Savara's rare lung disease therapy succeeds in late-stage study

Savara said on Wednesday its experimental therapy met the main goal of a late-stage trial by improving a measure of lung function in patients with a rare disease that causes

News|US

US FDA approves Verona Pharma's inhaled COPD therapy

The U.S.

US FDA approves Verona Pharma's inhaled COPD therapy
Business|Finance|US

Cassava Sciences forms internal panel after US probe into two employees

Cassava Sciences will form a committee to evaluatenew probes by U.S. regulators and investigate two senior employees, it said on Monday, days after a

Cassava Sciences forms internal panel after US probe into two employees

Follow